Hiroshi Suzuki Selected Research

Hiroshi Suzuki Research Topics

Disease

57	Infections 12/2021 - 01/2002
36	Human Influenza (Influenza) 05/2020 - 01/2002
27	Myocardial Infarction 04/2022 - 06/2003
26	Neoplasms (Cancer) 10/2020 - 05/2002
25	Gout 01/2022 - 11/2009
18	Breast Neoplasms (Breast Cancer) 01/2019 - 09/2004
17	Hyperuricemia 01/2022 - 12/2011
16	Inflammation (Inflammations) 01/2022 - 03/2004
13	Fibrosis (Cirrhosis) 01/2022 - 02/2006
11	Body Weight (Weight, Body) 04/2022 - 06/2003
11	Heart Failure 01/2022 - 04/2005
11	Malaria 03/2019 - 05/2007
10	Stroke (Strokes) 01/2022 - 10/2008
10	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 05/2002
9	Atherosclerosis 01/2019 - 03/2002
8	Thrombosis (Thrombus) 02/2022 - 07/2003
8	Hypertension (High Blood Pressure) 01/2022 - 01/2003
7	Hemorrhage 04/2022 - 01/2019
7	Dyslipidemias (Dyslipidemia) 01/2022 - 04/2006
7	Hepatocellular Carcinoma (Hepatoma) 03/2017 - 05/2002
7	Chronic Hepatitis C 10/2011 - 01/2002
6	Pathologic Constriction (Stenosis) 01/2022 - 05/2002
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 12/2006
6	ST Elevation Myocardial Infarction 04/2021 - 08/2013
6	Parasitemia 03/2020 - 01/2010
6	Coronary Disease (Coronary Heart Disease) 01/2019 - 12/2002
6	Hyperplasia 12/2018 - 02/2006
6	Ischemia 06/2016 - 10/2005
6	Neointima 01/2014 - 09/2002
6	Liver Diseases (Liver Disease) 10/2012 - 01/2003
5	Spasm (Spasms) 01/2022 - 08/2008
5	Heart Diseases (Heart Disease) 01/2021 - 06/2003
5	Chromosome Aberrations (Chromosome Abnormalities) 12/2018 - 08/2011
5	Neoplasm Metastasis (Metastasis) 11/2014 - 09/2008
5	Fever (Fevers) 12/2012 - 02/2008
5	Cholestasis 02/2011 - 09/2006
5	Carcinogenesis 12/2009 - 02/2003
4	Atrial Fibrillation 07/2022 - 08/2009
4	Atherosclerotic Plaque (Atheroma) 02/2022 - 01/2016
4	Acute Coronary Syndrome 01/2022 - 04/2006
4	Unstable Angina 01/2022 - 08/2017
4	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2022 - 07/2003
4	Death (Near-Death Experience) 01/2022 - 01/2019
4	Squamous Cell Carcinoma of Head and Neck 01/2021 - 01/2014
4	Necrosis 12/2020 - 11/2005
4	Non-alcoholic Fatty Liver Disease 12/2019 - 10/2011
4	Hyperlipidemias (Hyperlipidemia) 01/2019 - 09/2003
4	Disease Progression 01/2019 - 02/2008
4	Chronic Limb-Threatening Ischemia 01/2017 - 11/2008

Drug/Important Bio-Agent (IBA)

38	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2003
21	Uric Acid (Urate)IBA 01/2022 - 11/2009
20	Pharmaceutical PreparationsIBA 01/2021 - 01/2002
14	Antiviral Agents (Antivirals)IBA 12/2018 - 01/2003
13	Amantadine (Aman)FDA LinkGeneric 04/2010 - 01/2002
12	Oseltamivir (Tamiflu)FDA Link 01/2017 - 09/2003
11	CholesterolIBA 08/2020 - 12/2002
9	CytokinesIBA 01/2022 - 04/2005
9	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 12/2002
9	urate transporterIBA 11/2021 - 01/2013
9	AntigensIBA 05/2020 - 01/2003
9	ASP2151IBA 12/2018 - 08/2010
8	Vitamin E FDA LinkGeneric 06/2021 - 11/2009
8	oxidized low density lipoproteinIBA 01/2014 - 12/2002
7	DNA Primase (Primase)IBA 12/2018 - 08/2010
7	Erythropoietin FDA Link 01/2018 - 06/2006
7	CollagenIBA 12/2017 - 02/2006
7	EnzymesIBA 03/2016 - 05/2003
7	Messenger RNA (mRNA)IBA 08/2015 - 10/2004
7	Zanamivir (Relenza)FDA Link 01/2014 - 12/2002
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2003
6	AntibodiesIBA 01/2020 - 03/2002
6	LipidsIBA 03/2019 - 09/2003
6	ImmunosorbentsIBA 03/2016 - 12/2003
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2015 - 04/2006
6	Neuraminidase (Sialidase)IBA 01/2014 - 10/2004
6	Multidrug Resistance-Associated Protein 2IBA 02/2013 - 05/2002
6	Scavenger Receptors (Scavenger Receptor)IBA 06/2010 - 03/2002
5	Phenobarbital (Luminal)FDA Link 02/2022 - 05/2002
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 09/2005
5	Angiotensin Receptor AntagonistsIBA 01/2022 - 09/2006
5	ATP-Binding Cassette Transporters (ABC Transporters)IBA 11/2021 - 01/2003
5	Ezetimibe (Zetia)FDA Link 08/2020 - 02/2015
5	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 04/2006
5	Tocopherols (Tocopherol)IBA 03/2019 - 11/2011
5	Probucol (Lorelco)FDA Link 03/2019 - 01/2015
5	Valacyclovir (Valtrex)FDA LinkGeneric 12/2018 - 08/2010
5	Peptides (Polypeptides)IBA 01/2017 - 09/2005
5	InterferonsIBA 12/2014 - 01/2002
4	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 04/2022 - 10/2017
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 09/2016
4	Biological ProductsIBA 01/2021 - 06/2006
4	Insulin (Novolin)FDA Link 01/2020 - 01/2009
4	Glutathione (Reduced Glutathione)IBA 01/2017 - 10/2011

Therapy/Procedure

40	Therapeutics 04/2022 - 12/2002
15	Stents 01/2022 - 05/2002
10	Percutaneous Coronary Intervention 01/2022 - 08/2013
9	Drug Therapy (Chemotherapy) 03/2022 - 09/2004
5	Aftercare (After-Treatment) 01/2021 - 02/2008
4	Catheter Ablation 07/2022 - 07/2017
4	Drug-Eluting Stents 04/2022 - 05/2013